ArticleCureus2025
Clinicomycological Profile of Dermatophytosis in a Tertiary Care Hospital in Tamil Nadu, India.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Dermatophytosis, a prevalent superficial fungal infection, has emerged as a significant public health concern in India, warranting comprehensive investigations to understand its clinicomycological profile. This study aimed to analyze the demographic, clinical, and mycological patterns of dermatophytosis in patients attending a tertiary care center in Tamil Nadu, with a particular focus on species identification given the changing epidemiology and emerging antifungal resistance in the region. Methodology This cross-sectional study included 194 clinically diagnosed dermatophytosis cases visiting the Dermatology Outpatient Department from March 2022 to February 2023. Socio-demographic data, clinical presentations, and laboratory findings were recorded. Samples, including skin scrapings, nail clippings, and epilated hair, were collected by dermatologists and processed by trained laboratory technicians. Fungal isolates were identified based on colony morphology and microscopic characteristics. Results The study population comprised 112 (57.7%) males and 82 (42.3%) females. The predominant age group was 21-30 years old, observed in 59 (30.4%) cases. Acute presentations (<1 month) were most frequent with 92 (47.4%) cases, followed by chronic cases (>3 months) with 63 (32.5%) cases. Family members were the primary source of infection in 56 (28.9%) cases. Laboratory analysis revealed potassium hydroxide (KOH) positivity in 148 (76.3%) cases and culture positivity in 169 (87.1%) cases. Tinea corporis was the predominant clinical presentation, with 114 (58.7%) cases, followed by tinea cruris, with 39 (20.1%) cases. Risk factor analysis identified male gender (OR: 1.86, 95% CI: 1.24-2.78), family contact (OR: 2.34, 95% CI: 1.52-3.60), age >20 years (OR: 1.67, 95% CI: 1.12-2.49), and duration >3 months (OR: 1.93, 95% CI: 1.28-2.91) as significant risk factors. Mycological analysis revealed
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.